Sanofi India expands diabetes portfolio
Launches two diabetes drugs in India, Lyxumia, Zemiglo
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
UPS expands clinical trial logistics capabilities to support drug, vaccine research
To make key investments in technology, temperature-control capabilities and customer service
Ajanta Pharma receives ANDA approval for omeprazole and sodium bicarbonate capsules
The company has launched the product in two strengths 20mg/1100mg and 40mg/1100mg capsules
SPARC licenses ELEPSIA XR (levetiracetam ER tablets) to Sun Pharma
SPARC will receive an up-front payment of $10 million from Sun Pharma
VICAM gets 2016 North American Food Safety Diagnostics Market Leadership Award from Frost &…
Award recognises VICAM’s significant contributions to the safety and quality of the global food supply chain
DRL launches omeprazole and sodium bicarbonate capsules in US
A therapeutic equivalent of ZEGERID capsules, DRL's offerings are are available in bottle count size of 30
Dr Reddy’s…
Sugar-binding protein galectin-9 found to be a new weapon to cure HIV
It potently forces latent HIV out of hiding, and poisons the virus on its way out
Biocon’s insulin Glargine launched in Japan
The company through its partner aims to capture a significant share of the Japanese Glargine market
FDA approves dedicated syringe for use with Humulin R U-500 insulin
It is is the only device approved for use with U-500 insulin vial
Sun Pharma launches Gemcitabine InfuSMART, RTA bag for oncology treatment
Developed by Sun Pharma’s R&D team in India, InfuSMART will be rolled out across six countries - Netherlands, UK, Spain,…